|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 |
| (11) | Number of the document | 2023940 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07811875.9 |
| Date of filing the European patent application | 2007-05-07 | |
| (97) | Date of publication of the European application | 2009-02-18 |
| (45) | Date of publication and mention of the grant of the patent | 2011-06-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/068406 |
| Date | 2007-05-07 |
| (87) | Number | WO 2007/143316 |
| Date | 2007-12-13 |
| (30) | Number | Date | Country code |
| 746631 P | 2006-05-05 | US | |
| 747059 P | 2006-05-11 | US | |
| 805660 P | 2006-06-23 | US | |
| 864554 P | 2006-11-06 | US | |
| PCT/US2007/0611 | 2007-01-27 | WO |
| (72) |
BHANOT, Sanjay, US
GEARY, Richard, S., US
MCKAY, Robert, US
MONIA, Brett, P., US
SETH, Punit, P., US
SIWKOWSKI, Andrew, M., US
SWAYZE, Eric, E., US
WANCEWICZ, Edward, US
|
| (73) |
Isis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF SGLT2 |
| COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF SGLT2 |